ADH7 and gastric cancer: Besides their involvement in metabolizing exogenous substances through cytochrome P450 and drug metabolic pathways, ADH7, ALDH3A1, and ADH1B are also cross-genes with high connectivity within these pathways, indicating their potential use as diagnostic and prognostic biomarkers for gastric cancer (Zhao et al. 2017).